Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1321
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00142155 | Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia | ||
| NCT00889187 | Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer | ||
| NCT00578149 | Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer | ||
| NCT00686855 | Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease | ||
| NCT01844999 | Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks | ||
| NCT00148655 | Educational Interventions for Patients With DCIS | ||
| NCT04330716 | Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers | ||
| NCT03141671 | Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509) | ||
| NCT04908852 | Feasibility Pilot Exploring Variability in Biomarkers and PROs in AML | ||
| NCT04724018 | Sacituzumab Govitecan Plus EV in Metastatic UC | ||
| NCT06907797 | Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing | ||
| NCT01543620 | Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis | ||
| NCT02756390 | CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors | ||
| NCT06677190 | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin | ||
| NCT07563010 | Menin-Inhibitor Targeted Maintenance in AML | ||
| NCT01024946 | Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity | ||
| NCT00165191 | Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus | ||
| NCT00345540 | Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer | ||
| NCT00476190 | ALL Adult Consortium Trial: Adult ALL Trial | ||
| NCT02876302 | Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer | ||
| NCT00879034 | A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria | ||
| NCT03777410 | Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma | ||
| NCT00146588 | Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer | ||
| NCT04024761 | A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation | ||
| NCT01380782 | BIBF 1120 for Recurrent High-Grade Gliomas | ||
| NCT04789486 | Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer | ||
| NCT02520713 | The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study | ||
| NCT05584540 | UNTIRE: Cancer-related Fatigue With Digital Treatment | ||
| NCT02441686 | Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma | ||
| NCT00976898 | Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma | ||
| NCT00137852 | Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer | ||
| NCT00121134 | Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer | ||
| NCT01838564 | The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology | ||
| NCT01067287 | Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation | ||
| NCT00140504 | Preventing Adverse Drug Events With PatientSite | ||
| NCT00280930 | Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer | ||
| NCT01574937 | XL-184+Abiraterone in Post-Chemo CRPC | ||
| NCT03392090 | SHARE (Sharing Goals and Preferences) Study | ||
| NCT04040725 | Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression | ||
| NCT07732140 | Listen Aphasia Pilot Study | ||
| NCT01799135 | Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC) | ||
| NCT00139243 | Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck | ||
| NCT06366347 | ALPINE: Maintenance Letrozole/Abemaciclib | ||
| NCT03414658 | The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer | ||
| NCT00083031 | Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer | ||
| NCT00215202 | Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC) | ||
| NCT00136422 | Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia | ||
| NCT06313437 | Revumenib in Combination With 7+3 + Midostaurin in AML | ||
| NCT06582914 | Lynch Syndrome Integrative Epidemiology and Genetics | ||
| NCT07148180 | A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax |
